Ondansetron Injection, Solution
Product Images NDC 71872-7162

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71872-7162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (71872 7162 1 Pdp)

This is information about Ondansetron Injection, USP, which comes in a 2mL single-use Fliptop Vial with a dosage of 4mg/2mL. The solution contains ondansetron hydrochloride dihydrate, sodium chloride, citric acid anhydrous, and sodium citrate dihydrate as buffers in an aqueous solution. The recommended storage temperature is 20° to 25°C, but it can be stored in a refrigerator at 2 to 8°C. The product needs to be kept away from light and retained in the carton until use. The package insert provides information about dosage and administration. The product is sterile and manufactured for Hospra and repackaged by Medical Purchasing Solutions.*

FDA Label Image

Chemical Structure (Ondansetron 01)

FDA Label Image

Logo (Ondansetron 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

This is a description of a 2 mL single-dose vial of Ondansetron Injection, USP. The vial has an NDC code of 0409-4, and contains 4 mg/2 mL (2 mg/mL) of ondansetron. It should be protected from light during storage. The distributor is Hospira, Inc. in Lake Forest, IL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.